Skip to main content

Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya.

Publication ,  Journal Article
Mungo, C; Osongo, CO; Ambaka, J; Randa, MA; Omoto, J; Cohen, CR; Huchko, M
Published in: JCO Glob Oncol
July 2020

PURPOSE: The WHO now recommends thermal ablation as an alternative to cryotherapy within "screen-and-treat" cervical cancer programs in low- and middle-income countries (LMICs). We conducted a safety and acceptability clinical trial of thermal ablation in a Kenyan Ministry of Health hospital among women living with HIV (WLWH; ClinicalTrials.gov identifier: NCT04191967). METHODS: Between August 2019 and February 2020, WLWH age 25-65 years underwent human papillomavirus (HPV) self-collection in western Kenya. HPV-positive women underwent visual inspection with acetic acid, biopsy, and treatment with thermal ablation performed by a nonphysician clinician, if eligible by standard guidelines. A questionnaire was administered after treatment to assess for pain and treatment acceptability. Adverse events (AEs) were evaluated 4-6 weeks after treatment with a standardized grading tool. RESULTS: A total of 293 HPV-positive WLWH underwent thermal ablation in the study period. The mean age was 40.4 years (standard deviation, 8.7 years). After treatment, 15 (5.1%), 231 (78.8%), 42 (14.3%), and 5 (1.8%) reported none, mild, moderate, and severe pain with treatment, respectively. At follow-up, spotting, vaginal discharge, and pelvic pain were reported by 99 (37.8%), 258 (98.5%), and 46 (17.6%), respectively, for a median of 3.3 (interquartile range [IQR], 2-3), 14 (IQR, 7-21), and 7 (IQR, 3-7) days, respectively. Most participants graded their AEs as mild (grade 1): 94 (95.0%) for bleeding, 125 (48.5%) for vaginal discharge, and 37 (80.4%) for pelvic pain. No grade 3 or 4 AEs were reported. The vast majority (99.2%) were satisfied with the treatment and would recommend it to a friend. CONCLUSION: Thermal ablation performed by nonphysicians in the public health sector in Kenya proved safe and highly acceptable in treating HPV-positive WLWH.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

JCO Glob Oncol

DOI

EISSN

2687-8941

Publication Date

July 2020

Volume

6

Start / End Page

1024 / 1033

Location

United States

Related Subject Headings

  • Papillomavirus Infections
  • Papillomaviridae
  • Middle Aged
  • Kenya
  • Humans
  • HIV Infections
  • Female
  • Alphapapillomavirus
  • Aged
  • Adult
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Mungo, C., Osongo, C. O., Ambaka, J., Randa, M. A., Omoto, J., Cohen, C. R., & Huchko, M. (2020). Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya. JCO Glob Oncol, 6, 1024–1033. https://doi.org/10.1200/GO.20.00035
Mungo, Chemtai, Cirilus Ogollah Osongo, Jeniffer Ambaka, Magdalene A. Randa, Jackton Omoto, Craig R. Cohen, and Megan Huchko. “Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya.JCO Glob Oncol 6 (July 2020): 1024–33. https://doi.org/10.1200/GO.20.00035.
Mungo C, Osongo CO, Ambaka J, Randa MA, Omoto J, Cohen CR, et al. Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya. JCO Glob Oncol. 2020 Jul;6:1024–33.
Mungo, Chemtai, et al. “Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya.JCO Glob Oncol, vol. 6, July 2020, pp. 1024–33. Pubmed, doi:10.1200/GO.20.00035.
Mungo C, Osongo CO, Ambaka J, Randa MA, Omoto J, Cohen CR, Huchko M. Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya. JCO Glob Oncol. 2020 Jul;6:1024–1033.

Published In

JCO Glob Oncol

DOI

EISSN

2687-8941

Publication Date

July 2020

Volume

6

Start / End Page

1024 / 1033

Location

United States

Related Subject Headings

  • Papillomavirus Infections
  • Papillomaviridae
  • Middle Aged
  • Kenya
  • Humans
  • HIV Infections
  • Female
  • Alphapapillomavirus
  • Aged
  • Adult